CAXTON CORP Diversified Active

Location: Princeton, NJ

CIK: 0001388551 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 14, 2018

Total Value: $82.26M (100.0% shares, 0.0% debt)

Holdings (20)

STRONGBRIDGE BIOPHARMA PLC 48.6%
Value $39.98M Shares 5,514,994 Est. Cost $2.51 Unrealized
MOLECULAR TEMPLATES INC 12.3%
Value $10.16M Shares 1,013,787 Est. Cost $6.97 Unrealized
KALA PHARMACEUTICALS INC 12.2%
Value $10.06M Shares 544,220 Est. Cost $22.84 Unrealized
GARRISON CAP INC 9.9%
Value $8.11M Shares 1,000,000 Est. Cost $8.46 Unrealized
AGILE THERAPEUTICS INC 6.0%
Value $4.896M Shares 1,820,012 Est. Cost $6.12 Unrealized
BRK/B BERKSHIRE HATHAWAY INC DEL 2.2%
Value $1.773M Shares 8,945 Est. Cost $132.86 Unrealized +42.9%
JBGS JBG SMITH PPTYS 1.7%
Value $1.43M Shares 41,170 Est. Cost $34.27 Unrealized
IWM ISHARES TR 1.2%
Value $997K Shares 6,540 Est. Cost Unrealized
GTX INC DEL 1.0%
Value $799K Shares 62,869 Est. Cost $8.45 Unrealized
SPY SPDR S&P 500 ETF TR 0.8%
Value $672K Shares 2,519 Est. Cost Unrealized
CM FIN INC 0.7%
Value $574K Shares 70,402 Est. Cost $9.31 Unrealized
ALCENTRA CAP CORP 0.6%
Value $500K Shares 59,562 Est. Cost $8.39 Unrealized
ACRS ACLARIS THERAPEUTICS INC 0.5%
Value $444K Shares 17,994 Est. Cost $25.00 Unrealized -2.6%
TRIANGLE CAP CORP 0.5%
Value $385K Shares 40,580 Est. Cost $9.49 Unrealized
INTEC PHARMA LTD JERUSALEM 0.5%
Value $375K Shares 72,782 Est. Cost $8.94 Unrealized
ADNT ADIENT PLC 0.5%
Value $373K Shares 4,737 Est. Cost $50.50 Unrealized +57.5%
FS INVT CORP 0.3%
Value $226K Shares 30,706 Est. Cost $7.36 Unrealized
MDGL MADRIGAL PHARMACEUTICALS INC 0.3%
Value $222K Shares 2,418 Est. Cost $57.12 Unrealized 0.0%
MARINUS PHARMACEUTICALS INC 0.2%
Value $152K Shares 18,643 Est. Cost $6.17 Unrealized
CPRX CATALYST PHARMACEUTICALS INC 0.2%
Value $129K Shares 33,110 Est. Cost $3.30 Unrealized 0.0%